Recombinant CD73 (Uliledlimab Biosimilar) antibody

Catalog No. ABIN7598071

The Humanized Chimeric anti-CD73 (Uliledlimab Biosimilar) antibody has been validated for . It is suitable to detect CD73 (Uliledlimab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD73 (Uliledlimab Biosimilar) antibody (ABIN7598071)

Target: CD73 (Uliledlimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD73 (Uliledlimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD73 (Uliledlimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Uliledlimab Biosimilar Antibody

Specificity: CD73, 5'-nucleotidase, NT5E, NT5, 5'-NT, Ecto-5'-nucleotidase, NTE

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD73 (Uliledlimab Biosimilar)

Target: CD73 (Uliledlimab Biosimilar)

Alternative Name: Uliledlimab Biosimilar

Target Type: Biosimilar

Background: CD73, 5'-nucleotidase, NT5E, NT5, 5'-NT, Ecto-5'-nucleotidase, NTE

UniProt: P21589

CAS-No: 2378407-27-1